Canopy Growth (CGC) Asset Writedowns and Impairment (2020 - 2023)

Canopy Growth (CGC) reported Asset Writedowns and Impairment of $7.9 million for Q2 2023, down 99.42% on a YoY basis from $1.4 billion in Q2 2022, and down 97.14% sequentially from $275.7 million in Q1 2023.

Canopy Growth (CGC) Asset Writedowns and Impairment (2020 - 2023) Analysis & Trends

Canopy Growth (CGC) has 4 years of Asset Writedowns and Impairment data on file, last reported at $7.9 million in Q2 2023.

  • For the quarter ending Q2 2023, Asset Writedowns and Impairment fell 99.42% year-over-year to $7.9 million; the trailing twelve-month figure through Jun 2023 stood at $379.0 million (down 75.59% YoY), and the FY2023 full-year result was $1.6 billion, up 520.41% from the prior year.
  • Asset Writedowns and Impairment slipped to $7.9 million in Q2 2023, from $275.7 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $1.4 billion in Q2 2022 to a low of -$809503.1 in Q3 2021.
  • A 4-year average of $209.4 million and a median of $76.3 million in 2021 frame the typical range for Asset Writedowns and Impairment.
  • Across the five-year window, Asset Writedowns and Impairment surged 10927.04% in 2022 and sank 99.42% in 2023, its largest moves.
  • Tracing CGC's Asset Writedowns and Impairment over 4 years: stood at $228.7 million in 2020, then tumbled by 88.71% to $25.8 million in 2021, then sank by 69.77% to $7.8 million in 2022, then gained by 0.88% to $7.9 million in 2023.
  • Business Quant data shows CGC's Asset Writedowns and Impairment at $7.9 million in Q2 2023, $275.7 million in Q1 2023, and $7.8 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.42 Bn 87.55 Bn -
2 Teva Pharmaceutical Industries 35.89 Bn 32.15 Bn 1.97 Bn
3 Zoetis 32.44 Bn 30.50 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.55 Bn 23.49 Bn 4.39 Bn
5 United Therapeutics 23.13 Bn 20.98 Bn 648.10 Mn
6 RedHill Biopharma 21.17 Bn 21.17 Bn -
7 Viatris 20.33 Bn 18.53 Bn 1.16 Bn
8 Neurocrine Biosciences 17.77 Bn 16.45 Bn 800.70 Mn
9 Elanco Animal Health 12.63 Bn 12.20 Bn 785.00 Mn
10 Canopy Growth 281.68 Mn 15.75 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 7.88 Mn
Jun 30, 2023 7.88 Mn
Mar 31, 2023 275.71 Mn
Mar 31, 2023 275.71 Mn
Dec 31, 2022 7.81 Mn
Dec 31, 2022 7.81 Mn
Sep 30, 2022 87.65 Mn
Sep 30, 2022 87.65 Mn
Jun 30, 2022 1.35 Bn
Jun 30, 2022 1.35 Bn
Mar 31, 2022 173.45 Mn
Mar 31, 2022 173.45 Mn
Dec 31, 2021 25.83 Mn
Dec 31, 2021 25.83 Mn
Sep 30, 2021 -809,503.09
Sep 30, 2021 -809,503.09
Jun 30, 2021 66.47 Mn
Jun 30, 2021 66.47 Mn
Mar 31, 2021 76.32 Mn
Mar 31, 2021 76.32 Mn